Galectin Therapeutics Inc. (GALT)
NASDAQ: GALT · Real-Time Price · USD
2.815
+0.060 (2.18%)
Nov 20, 2024, 4:00 PM EST - Market closed

Galectin Therapeutics Statistics

Total Valuation

GALT has a market cap or net worth of $176.67 million. The enterprise value is $256.42 million.

Market Cap 176.67M
Enterprise Value 256.42M

Important Dates

The last earnings date was Wednesday, November 13, 2024, before market open.

Earnings Date Nov 13, 2024
Ex-Dividend Date n/a

Share Statistics

GALT has 62.76 million shares outstanding. The number of shares has increased by 4.27% in one year.

Current Share Class 62.76M
Shares Outstanding 62.76M
Shares Change (YoY) +4.27%
Shares Change (QoQ) +0.07%
Owned by Insiders (%) 20.30%
Owned by Institutions (%) 15.68%
Float 43.59M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio n/a
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 1.13

Current Ratio 1.13
Quick Ratio 1.07
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -8.49

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) -96.72%
Return on Capital (ROIC) -207.88%
Revenue Per Employee n/a
Profits Per Employee -$3.23M
Employee Count 14
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +43.62% in the last 52 weeks. The beta is 0.63, so GALT's price volatility has been lower than the market average.

Beta (5Y) 0.63
52-Week Price Change +43.62%
50-Day Moving Average 2.69
200-Day Moving Average 2.60
Relative Strength Index (RSI) 55.36
Average Volume (20 Days) 152,705

Short Selling Information

The latest short interest is 5.52 million, so 8.79% of the outstanding shares have been sold short.

Short Interest 5.52M
Short Previous Month 5.46M
Short % of Shares Out 8.79%
Short % of Float 12.66%
Short Ratio (days to cover) 42.37

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -39.57M
Pretax Income -44.65M
Net Income -45.23M
EBITDA n/a
EBIT -39.57M
Earnings Per Share (EPS) -$0.73
Full Income Statement

Balance Sheet

The company has $27.06 million in cash and $104.59 million in debt, giving a net cash position of -$77.53 million or -$1.24 per share.

Cash & Cash Equivalents 27.06M
Total Debt 104.59M
Net Cash -77.53M
Net Cash Per Share -$1.24
Equity (Book Value) -92.48M
Book Value Per Share -1.52
Working Capital 3.41M
Full Balance Sheet

Cash Flow

Operating Cash Flow -33.68M
Capital Expenditures n/a
Free Cash Flow -33.68M
FCF Per Share -$0.54
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

GALT does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -4.27%
Shareholder Yield -4.27%
Earnings Yield -25.60%
FCF Yield -19.06%

Analyst Forecast

The average price target for GALT is $11.00, which is 290.76% higher than the current price. The consensus rating is "Strong Buy".

Price Target $11.00
Price Target Difference 290.76%
Analyst Consensus Strong Buy
Analyst Count 1
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

The last stock split was on March 23, 2012. It was a reverse split with a ratio of 0.1666666:1.

Last Split Date Mar 23, 2012
Split Type Reverse
Split Ratio 0.1666666:1

Scores

Altman Z-Score n/a
Piotroski F-Score 1